1
Total investments
0
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2018
Beyond targets.
We accelerate the discovery and development of optimal candidate compounds for pre-clinical and clinical testing. Our proprietary GeneScapeTM platform enables applied modular biology and the identification of the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis.
Experience · 1 entries
All (1)
Investments (1)
Board (1)
2018
Board Member
Dec 2018
Beyond targets.
We accelerate the discovery and development of optimal candidate compounds for pre-clinical and clinical testing. Our proprietary GeneScapeTM platform enables applied modular biology and the identification of the optimal intersection between targets and compounds in specific disease spaces through whole-genome genetic perturbation and analysis.